Differential sustained attention/vigilance changes over time in schizophrenics and controls during a degraded stimulus Continuous Performance Test

European Archives of Psychiatry and Clinical Neuroscience

Volumn 250, Issue 1, 2000, Pages 24-30

  Mass, R ^a   Wolf, K ^a   Wagner, M ^b   Haasen, C ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Continuous Performance Test; Decrements of vigilance; Neuropsychology; Schizophrenia; Sustained attention

Indexed keywords

BENZODIAZEPINE; NEUROLEPTIC AGENT;

ADULT; ALERTNESS; ARTICLE; ATTENTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PERFORMANCE; PRIORITY JOURNAL; SCHIZOPHRENIA; VISUAL STIMULATION;

ADULT; ANTIPSYCHOTIC AGENTS; AROUSAL; ATTENTION; BENZODIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; EDUCATIONAL STATUS; FEMALE; HOSPITALIZATION; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PERCEPTUAL MASKING; PHOTIC STIMULATION; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; VISUAL PERCEPTION;

EID: 0034069544     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00007535     Document Type: Article

References (36)

1. Andreasen NC (1989) The Scale for the Assessment of Negative Symptoms (SANS): Conceptual and theoretical foundations. Br J Psychiatry 155(Suppl 7):49-52
2. Binder J, Albus M, Hubmann W, Scherer J, Sobizack N, Franz U, Mohr F, Hecht S (1998) Neuropsychological impairment and psychopathology in first-episode schizophrenic patients related to the early course of illness. Eur Arch Psychiatry Clin Neurosci 248:70-77
3. Braff DL (1993) Information processing and attention in schizophrenia. Schizophr Bull 19:233-259
4. Buchanan RW, Holstein C, Breier A (1994) The comparative efficacy and long-term effect of Clozapine treatment on neuropsychological test performance. Biol Psychiatry 36:717-725
5. Buchanan RW, Strauss ME, Breier A, Kirkpatrick B, Carpenter WT (1997) Attentional impairments in deficit and nondeficit forms of schizophrenia. Am J Psychiatry 154:363-370
6. Buchsbaum MS, Nuechterlein KH, Haier RJ, Wu J, Sicotte N, Hazlett E, Asarnow R, Potkin S, Guich S (1990) Glucose metabolic rate in normals and schizophrenics during the Continuous Performance Test assessed by positron emission tomography. Br J Psychiatry 156:216-227
7. Cornblatt BA, Lenzenweger MF, Erlenmeyer-Kimling L (1989) The Continuous Performance Test, identical pairs version: II. Contrasting attentional profiles in schizophrenic and depressed patients. Psychiatry Res 29:65-85
8. Cowan N (1988) Evolving conceptions of memory storage, selective attention, and their mutual constraints within the human information-processing system. Psychol Bull 104:163-191
9. Erlenmeyer-Kimling L (1987) Biological markers for the liability to schizophrenia. In: Helmchen H, Henn FA (eds), Biological Perspectives of Schizophrenia. John Wiley & Sons, Chichester, New York, Brisbane, Torinto, Singapore, pp 33-56
10. Green DM, Swets JA (1966) Signal detection theory and psychophysics. Wiley, New York
11. Green MF (1996) What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153: 321-330
12. Hain C, Maier W, Klingler T, Franke P (1993) Positive/negative symptomatology and experimental measures of attention in schizophrenic patients. Psychopathology 26:62-68
13. Hiller W, Zaudig M, Mombour W (1995) IDCL: Internationale Diagnosen-Checklisten für ICD-10 und DSM-IV. Huber, Bern
14. Jahn T, Mussgay L (1989) Die statistische Kontrolle möglicher Medikamenteneinflüsse in experimentalpsychologischen Schizophreniestudien: Ein Vorschlag zur Berechnung von Chlorpromazinäquivalenten. Z Klin Psychol 18:257-267
15. Kathmann N, Wagner M, Satzger W, Engel RR (1996) Vigilanzmessung auf Verhaltensebene: Der Continuous Performance Test - München (CPT-M). In: Möller H-J, Engel RR, Hoff P (eds) Befunderhebung in der Psychiatrie: Lebensqualität, Negativsymptomatik und andere aktuelle Entwicklungen. Springer, Wien, New York, pp 331-338
16. Kay SR, Fiszbein A, Opler LA (1987) The Positive and Negative Syndrome Scale PANSS for schizophrenia. Schizophr Bull 13: 261-276
17. Kietzman ML (1991) Information processing and schizophrenia. In: Steinhauer SR, Gruzelier JH, Zubin J (eds) Handbook of Schizophrenia: Neuropsychology, Psychophysiology and Information Processing. Elsevier Science Publishers B. V., Amsterdam, London, New York, Tokio, pp 227-239
18. Kraepelin E (1919) Dementia praecox and paraphrenia (translated by B. M. Barclay). Edinburgh: Livingstone (originally published 1913)
19. Maruff P, Currie J (1996) Neuropsychology of visual attentional deficits in schizophrenia. In: Pantelis C, Nelson HE, Barnes TRE (eds) Schizophrenia. A Neuro-Psychological Perspective. John Wiley & Sons, Chichester, New York, Brisbane, Toronto, Singapore, pp 87-105
20. Mass R, Schoemig T, Hitschfeld K, Wall E, Haasen C (in press) Psychopathological syndromes of schizophrenia. Evaluation of the dimensional structure of the Positive and Negative Syndrome Scale (PANSS). To be published in Schizophr Bull
21. Nestor PG, Faux SF, McCarley RW, Shenton ME, Sands SF (1990) Measurement of visual sustained attention in schizo-phrenia using signal detection analysis and a newly developed computerized CPT task. Schizophr Res 3:329-332
22. Nuechterlein KH (1983) Signal detection in vigilance tasks and behavioral attributes among offspring of schizophrenic mothers and among hyperactive children. J Abnorm Psychol 92:4-28
23. Nuechterlein KH (1991) Vigilance in schizophrenia and related disorders. In: Steinhauer SR, Gruzelier JH, Zubin J (eds) Handbook of Schizophrenia: Neuropsychology, Psychophysiology and Information Processing. Elsevier Science Publishers B. V., Amsterdam, London, New York. Tokio, pp 397-433
24. Nuechterlein KH, Asarnow RF (1996) Continuous Performance Test (CPT). Program for IBM-Compatible Microcomputers, Version 7.10, for the Degraded Stimulus CPT and Conventional "0" CPT. Nuechterlein KH, Asarnow RF, Los Angeles
25. Nuechterlein KH, Dawson ME, Green MF (1994) Information-processing abnormalities as neuropsychological vulnerability indicators for schizophrenia. Acta Psychiatrica Scandinavica 90:71-79
26. Nuechterlein KH, Dawson ME, Ventura J, Fogelson D, Gitlin M, Mintz J (1991) Testing vulnerability models: Stability of potential vulnerability indicators across clinical states. In: Haefner H, Gattaz WF (eds) Search for the Causes of Schizophrenia. Springer, Berlin, pp 177-191
27. Nuechterlein KH, Edell WS, Norris M, Dawson ME (1986) Attentional vulnerability indicators, thought disorder, and negative symptoms. Schizophr Bull 12:408-426
28. Nuechterlein KH, Parasuraman R, Jiang Q (1983) Visual sustained attention: Image degradation produces rapid sensitivity over time. Science 220:327-329
29. Overall JE, Gorham DR (1988) The Brief Psychiatric Rating Scale (BPRS): Recent developments in ascertainment and scaling. Psychopharmacol Bull 24:97-99
30. Parasuraman R (1979) Memory load and event rate control sensitivity decrements in sustained attention. Science 205:924-927
31. Poser W, Poser S (1986) Abusus und Abhängigkeit von Benzodiazepinen. Internist 27:738-745
32. Rosvold HE, Mirsky A, Sarason I, Bransome Jr ED, Beck LH (1956) A continuous performance test of brain damage. J Consult Psychol 20:343-350
33. Strauss ME, Buchanan RW, Hale J (1993) Relations between attentional deficits and clinical symptoms in schizophrenic out-patients. Psychiatry Res 47, 205-213
34. Weinberger DR (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660-669
35. Wohlberg GW, Kornetsky C (1973) Sustained attention in remitted schizophrenics. Arch Gen Psychiatry 28:533-537
36. World Health Organization (1992) The ICD-10 classification of mental and behavioral disorders. Clinical descriptions and diagnostic guidelines. World Health Organization, Geneva